One institutional analyst that constantly prowls the micro-cap space is Peel Hunt. And for 2026, its team of experts have highlighted two tiny companies with explosive potential: Jadestone Energy (LSE:JSE) and Shield Therapeutics (LSE:STX).

With market caps of £124m and £113m respectively, these businesses are just over the penny stock threshold of £100m. But with both shares trading for less than 25p, they’re still considered micro-cap opportunities for many investors.

So, why is Peel Hunt so bullish? And how much money could investors make if they buy shares today?

Oil & gas turnaround

Jadestone is a bit of a unique player within the oil & gas sector. Rather than try to find new discoveries, it acquires assets that are close to the end of their lifespan within the Asia-Pacific region. The goal is to buy projects cheaply and then extend their production life through operational efficiency improvements.

This strategy can be highly lucrative for a small player like Jadestone. And if the business hits its production target of 40,000 barrels of oil & equivalents per day, the team at Peel Hunt believes free cash flow could skyrocket, sending the stock price all the way to 50p by this time next year – a 122% gain from current levels.

However, to succeed, Jadestone will need to deliver solid operational execution. And in recent years, that’s proven to be quite challenging. Its flagship Montara project has been riddled with problems such as defects, corrosion, and multiple unplanned shutdowns.

Since repairing old production assets is expensive, the balance sheet has also come under strain, leaving many investors understandably sceptical. But if management can get operations back on track, Peel Hunt’s aggressive forecast might be spot on. Jadestone Energy is a classic high-risk, high-reward investment.

Turning iron into gold

The second near-penny stock on Peel Hunt’s list is Shield Therapeutics – a commercial stage pharma business focused on iron deficiency. Its flagship Accrufer oral iron supplement is already widely available throughout Europe. However, following a recent partnership with Viatris, Accrufer is going to the US healthcare market.

This culminated in the third quarter of 2025 being the strongest in the company’s history, with net revenues and average selling prices jumping by double-digits. And to top it off, free cash flow generation is also expected to turn positive before 2026 kicks off.

Considering the widespread issue of iron deficiency in the US, Shield Therapeutics is looking at an enormous growth opportunity. And it’s one that Peel Hunt thinks could send the share price flying to 15p – almost 35% higher than current levels.

But like Jadestone, performance next year will require good execution. Entering a new market is a lot more involved than simply making a product available. Shield Therapeutics now needs to convince US doctors to prescribe Accrufer to patients instead of existing therapies – something that’s far easier said than done.

Both of these near-penny stocks have impressive potential. But they also come with a single point of failure – a critical risk investors must consider carefully.

The post Prediction: these near-penny stocks could be among 2026’s big winners appeared first on The Motley Fool UK.

Is this the best small explorer around today or is there a better buy for my portfolio?

Solid results

Hurricane Energy’s assets are focused in the West of Shetland region of the UK. The first oil flowed from its flagship Lancaster field in June 2019.

In its 2022 half-year results, the company announced $159.5m in revenue compared to $124.5m in the same period last year. This generated $110.1m of operating cash flow, rising from $75.9m in H1 2021. Profit after tax was $67m.

Earlier this year, Hurricane repaid its outstanding $78.5m convertible bonds, plus interest. This left the company debt-free, and management is certainly bullish on the future: “With our strong balance sheet, no debt, and our decommissioning liabilities being fully funded… Hurricane, with our committed and capable team, is well placed to be able to create additional value for our shareholders.”

Risks

The main risk I see with Hurricane is the same that all smaller oil companies face, which is a sudden and/or sustained slump in the price of oil. Or even a crash.

For example, the pandemic and nationwide lockdowns caused a sharp decline in demand for oil and pushed refineries into production cuts. The price of oil collapsed, and at one point in 2020, a record 160 million barrels of excess oil were sitting in tankers around the world.

But oil demand rebounded strongly and Hurricane emerged in a relatively strong financial position. The problem is that nobody can predict what’s going to cause the next oil price crash and how long it will take to recover.

Safer options

Personally, I’d prefer one of the big players that has large cash reserves and can survive prolonged slumps in oil prices. Both BP and Shell, for example, look better options to me, with bucket loads of cash and assets.

These companies haven’t survived decades of tricky geopolitical situations and oil crises without being resilient. But needless to say, investing in such oil giants isn’t going to double my money overnight, like investing in Hurricane Energy could (in theory).

I’m looking elsewhere

However, beyond the safer oil giants, I do believe a better option for me could lie elsewhere. Jadestone Energy (LSE: JSE) is another small oil and gas producer, although focused on the Asia Pacific region. It has assets in Australia, Indonesia, Malaysia and Vietnam, but has been hit by operational problems in recent months. This has left the shares down 23% since January. But these issues should be transitory.

Jadestone Energy’s market cap is only £309m, just over double that of Hurricane’s. Its cash balance remains healthy and the company is also debt-free.

The risk with Jadestone is that operational problems may persist, eating away at its free cash flow at a time when oil prices are high. Still, I like Jadestone’s diversification of assets and the region it operates in, so I’m considering investing in the company over Hurricane Energy.

The post The Hurricane Energy share price is up 80% in 2022. Time to buy in November? appeared first on The Motley Fool UK.